New poultry vaccine plant in India

19-09-2007 | |

Globion India Private Limited, the newly-incorporated subsidiary of Suguna Poultry Group, is setting up a poultry vaccine manufacturing facility in Hyderabad.

“The Andhra Pradesh Industrial Infrastructure Corporation (APIIC) has allotted 10 acres to the company in phase III of the Genome Valley biotech park on the city outskirts, and we expect to start commercial production in 18 to 24 months from now,” said DK Dey, general manager (biotechnology), Globion India.
The facility will have a capacity of 5,000 million doses per year and produce multiple vaccines for dreadful poultry diseases including mareks, infectious bronchitis and infectious bursal disease. 
“Suguna felt it was essential to start vaccine manufacturing to cater to the needs of the poultry farmers across the country and ensure import substitution,” Dey said.
The group is the largest importer of poultry vaccines in India.
 
 

Join 31,000+ subscribers

Subscribe to our newsletter to stay updated about all the need-to-know content in the poultry sector, three times a week.
Worldpoultry